VIBE: Evaluation of Ibandronate Efficacy - Original Investigation
No prospective head-to-head trials comparing the fracture efficacy of the currently marketed weekly and monthly bisphosphonates have been conducted. Due to the large sample size such studies would require to reliably detect differences in fracture risk and the associated high costs, they are conside...
Main Authors: | J-Y Reginster, S Poston |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayinevi
2008-12-01
|
Series: | Türk Osteoporoz Dergisi |
Subjects: | |
Online Access: | http://www.turkosteoporozdergisi.org/article_4101/Vibe-Evaluation-Of-Ibandronate-Efficacy-Original-Investigation |
Similar Items
-
VIBE: Evaluation of Ibandronate Efficacy - Original Investigation
by: J-Y Reginster, et al.
Published: (2008-12-01) -
Review of once-monthly oral ibandronate and the use thereof
by: T De Villiers, et al.
Published: (2017-08-01) -
EFFECT OF IBANDRONATE ON RISKS FOR VERTEBRAL AND NONVERTEBRAL FRACTURES IN POSTMENOPAUSALOSTEOPOROSIS (A REVIEW OF CLINICAL TRIALS)
by: Evgeni Germanovich Zotkin
Published: (2010-06-01) -
EFFECT OF IBANDRONATE ON RISKS FOR VERTEBRAL AND NONVERTEBRAL FRACTURES IN POSTMENOPAUSALOSTEOPOROSIS (A REVIEW OF CLINICAL TRIALS)
by: Evgeni Germanovich Zotkin
Published: (2010-06-01) -
Gastrointestinal tolerability with ibandronate after previous weekly bisphosphonate treatment
by: Richard Derman, et al.
Published: (2009-09-01)